Nom du produit:2-Cyclobutyl-5-(piperidin-2-yl)-1,3,4-oxadiazole
IUPAC Name:2-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)piperidine
- CAS：1439898-03-9
- Formule moléculaire：C11H17N3O
- Pureté：97%
- Numéro de catalogue：CM504710
- Poids moléculaire：207.28
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1439898-03-9
- Formule moléculaire:C11H17N3O
- Point de fusion:-
- Code SMILES:C1(C2=NN=C(C3CCC3)O2)NCCCC1
- Densité:
- Numéro de catalogue:CM504710
- Poids moléculaire:207.28
- Point d'ébullition:
- N° Mdl:MFCD26096913
- Stockage:
Category Infos
- Piperidines
- Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.
- Piperidine,Piperidine Price
- if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.
- Oxadiazoles
- Oxadiazoles are a class of heterocyclic aromatic compounds with the molecular formula C2H2N2O, which have special biological activities and thermodynamic properties. Five-membered heterocyclic moieties composed of three or two heteroatoms are of great interest to researchers because these compounds show significant therapeutic potential. These heterocycles can serve as a building block for the development of novel molecular structures.
- Cyclobutanes
- The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.
Recherche 
+86 21 5895 0110 
